Driven by purpose. Inspired by people.

How Diag-Nose.io Started

Diag-Nose.io was founded in 2020 by a team of ENT specialists, bioengineers, and entrepreneurs at Stanford’s EENT Innovation Program. We began with a simple question: why do patients with similar respiratory symptoms respond so differently to treatment?

That led to our unique insight: “Even when symptoms overlap, each patient’s airway biology is as unique as their fingerprint.”

By tapping into nasal fluid and decoding its biological signals (“omics”), we saw a path to predict drug response, reduce side effects, and improve treatment adherence.

With enough data, we realized we could go even further: discover new lifesaving medicines and solve long-standing gaps in respiratory care to make sure every patient receives treatment that works.